Efficient workflow for validating homology-independent targeted integration-mediated gene insertion in rod photoreceptor cells to treat dominant-negative mutations causing retinitis pigmentosa
Preprint
Abstract
Among the genome-editing methods for repairing disease-causing mutations resulting in dominant inhibition, homology-independent targeted integration (HITI)-mediated gene insertion of the normal form of the causative gene is useful because it allows the development of mutation-agnostic therapeutic products. For the rapid optimization and validation of highly effective HITI-treatment gene constructs against dominant-negative inheritance of inherited retinal dystrophy, we improved the gene constructs available in both plasmid and adeno-associated virus (AAV) vectors, and established a workflow that uses in vivo electroporation to verify the in vivo efficacy. By targeting the mouse Rhodopsin gene, we derived a construct in which HITI-mediated gene insertion occurs in 80%-90% of transduced mouse rod photoreceptor cells. This construct suppressed degeneration and induced visual restoration in the mutant mice. The HITI-treatment constructs for the rhodopsin gene were shown to be effective in AAV vectors, and this construction is available for the mouse Peripherin 2 gene. These findings suggest that the workflow reported here may be useful for the generation of HITI-treatment constructs for various target genes and for the development of gene therapy products.Keywords
This publication has 45 references indexed in Scilit:
- A Review on Advanced CRISPR-Based Genome-Editing Tools: Base Editing and Prime EditingMolecular Biotechnology, 2022
- Gene therapy clinical trials, where do we go? An overviewBiomedicine & Pharmacotherapy, 2022
- PRPH2 mutation update: In silico assessment of 245 reported and 7 novel variants in patients with retinal diseaseHuman Mutation, 2021
- Protocol for De Novo Gene Targeting Via In Utero Electroporation2021
- Genetic Basis of Inherited Retinal Disease in a Molecularly Characterized Cohort of More Than 3000 Families from the United KingdomOphthalmology, 2020
- Pronuclear Microinjection during S-Phase Increases the Efficiency of CRISPR-Cas9-Assisted Knockin of Large DNA Donors in Mouse ZygotesCell Reports, 2020
- The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapyProgress in Retinal and Eye Research, 2018
- Pias3-Dependent SUMOylation Directs Rod Photoreceptor DevelopmentNeuron, 2009
- Expression and localization of an exogenous G protein-coupled receptor fused with the rhodopsin C-terminal sequence in the retinal rod cells of knockin miceExperimental Eye Research, 2005
- Preparing Rod Outer Segment Membranes, Regenerating Rhodopsin, and Determining Rhodopsin Concentration1993